Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Human Prothrombin Complex Market Growth 2022-2028

  • LP 4711451
  • 98 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Human Prothrombin Complex will have significant change from previous year. According to our (LP Information) latest study, the global Human Prothrombin Complex market size is USD million in 2022 from USD 1542.7 million in 2021, with a change of % between 2021 and 2022. The global Human Prothrombin Complex market size will reach USD 3462.1 million in 2028, growing at a CAGR of 12.2% over the analysis period.

The United States Human Prothrombin Complex market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Prothrombin Complex market, reaching US$ million by the year 2028. As for the Europe Human Prothrombin Complex landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Human Prothrombin Complex players cover Takeda, CSL, Grifols, and Octapharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Prothrombin Complex market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

500 IU/Vial

600 IU/Vial

1000 IU/Vial

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hemophilia B

Vitamin K Deficiency

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Takeda

CSL

Grifols

Octapharma

Hualan Biological

Meheco Xinxing Pharma

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Human Prothrombin Complex Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Human Prothrombin Complex by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Human Prothrombin Complex by Country/Region, 2017, 2022 & 2028

2.2 Human Prothrombin Complex Segment by Type

2.2.1 500 IU/Vial

2.2.2 600 IU/Vial

2.2.3 1000 IU/Vial

2.2.4 Others

2.3 Human Prothrombin Complex Sales by Type

2.3.1 Global Human Prothrombin Complex Sales Market Share by Type (2017-2022)

2.3.2 Global Human Prothrombin Complex Revenue and Market Share by Type (2017-2022)

2.3.3 Global Human Prothrombin Complex Sale Price by Type (2017-2022)

2.4 Human Prothrombin Complex Segment by Application

2.4.1 Hemophilia B

2.4.2 Vitamin K Deficiency

2.4.3 Others

2.5 Human Prothrombin Complex Sales by Application

2.5.1 Global Human Prothrombin Complex Sale Market Share by Application (2017-2022)

2.5.2 Global Human Prothrombin Complex Revenue and Market Share by Application (2017-2022)

2.5.3 Global Human Prothrombin Complex Sale Price by Application (2017-2022)

3 Global Human Prothrombin Complex by Company

3.1 Global Human Prothrombin Complex Breakdown Data by Company

3.1.1 Global Human Prothrombin Complex Annual Sales by Company (2020-2022)

3.1.2 Global Human Prothrombin Complex Sales Market Share by Company (2020-2022)

3.2 Global Human Prothrombin Complex Annual Revenue by Company (2020-2022)

3.2.1 Global Human Prothrombin Complex Revenue by Company (2020-2022)

3.2.2 Global Human Prothrombin Complex Revenue Market Share by Company (2020-2022)

3.3 Global Human Prothrombin Complex Sale Price by Company

3.4 Key Manufacturers Human Prothrombin Complex Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Human Prothrombin Complex Product Location Distribution

3.4.2 Players Human Prothrombin Complex Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Human Prothrombin Complex by Geographic Region

4.1 World Historic Human Prothrombin Complex Market Size by Geographic Region (2017-2022)

4.1.1 Global Human Prothrombin Complex Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Human Prothrombin Complex Annual Revenue by Geographic Region

4.2 World Historic Human Prothrombin Complex Market Size by Country/Region (2017-2022)

4.2.1 Global Human Prothrombin Complex Annual Sales by Country/Region (2017-2022)

4.2.2 Global Human Prothrombin Complex Annual Revenue by Country/Region

4.3 Americas Human Prothrombin Complex Sales Growth

4.4 APAC Human Prothrombin Complex Sales Growth

4.5 Europe Human Prothrombin Complex Sales Growth

4.6 Middle East & Africa Human Prothrombin Complex Sales Growth

5 Americas

5.1 Americas Human Prothrombin Complex Sales by Country

5.1.1 Americas Human Prothrombin Complex Sales by Country (2017-2022)

5.1.2 Americas Human Prothrombin Complex Revenue by Country (2017-2022)

5.2 Americas Human Prothrombin Complex Sales by Type

5.3 Americas Human Prothrombin Complex Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Human Prothrombin Complex Sales by Region

6.1.1 APAC Human Prothrombin Complex Sales by Region (2017-2022)

6.1.2 APAC Human Prothrombin Complex Revenue by Region (2017-2022)

6.2 APAC Human Prothrombin Complex Sales by Type

6.3 APAC Human Prothrombin Complex Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Human Prothrombin Complex by Country

7.1.1 Europe Human Prothrombin Complex Sales by Country (2017-2022)

7.1.2 Europe Human Prothrombin Complex Revenue by Country (2017-2022)

7.2 Europe Human Prothrombin Complex Sales by Type

7.3 Europe Human Prothrombin Complex Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Human Prothrombin Complex by Country

8.1.1 Middle East & Africa Human Prothrombin Complex Sales by Country (2017-2022)

8.1.2 Middle East & Africa Human Prothrombin Complex Revenue by Country (2017-2022)

8.2 Middle East & Africa Human Prothrombin Complex Sales by Type

8.3 Middle East & Africa Human Prothrombin Complex Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Human Prothrombin Complex

10.3 Manufacturing Process Analysis of Human Prothrombin Complex

10.4 Industry Chain Structure of Human Prothrombin Complex

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Human Prothrombin Complex Distributors

11.3 Human Prothrombin Complex Customer

12 World Forecast Review for Human Prothrombin Complex by Geographic Region

12.1 Global Human Prothrombin Complex Market Size Forecast by Region

12.1.1 Global Human Prothrombin Complex Forecast by Region (2023-2028)

12.1.2 Global Human Prothrombin Complex Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Human Prothrombin Complex Forecast by Type

12.7 Global Human Prothrombin Complex Forecast by Application

13 Key Players Analysis

13.1 Takeda

13.1.1 Takeda Company Information

13.1.2 Takeda Human Prothrombin Complex Product Offered

13.1.3 Takeda Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Takeda Main Business Overview

13.1.5 Takeda Latest Developments

13.2 CSL

13.2.1 CSL Company Information

13.2.2 CSL Human Prothrombin Complex Product Offered

13.2.3 CSL Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 CSL Main Business Overview

13.2.5 CSL Latest Developments

13.3 Grifols

13.3.1 Grifols Company Information

13.3.2 Grifols Human Prothrombin Complex Product Offered

13.3.3 Grifols Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Grifols Main Business Overview

13.3.5 Grifols Latest Developments

13.4 Octapharma

13.4.1 Octapharma Company Information

13.4.2 Octapharma Human Prothrombin Complex Product Offered

13.4.3 Octapharma Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Octapharma Main Business Overview

13.4.5 Octapharma Latest Developments

13.5 Hualan Biological

13.5.1 Hualan Biological Company Information

13.5.2 Hualan Biological Human Prothrombin Complex Product Offered

13.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Hualan Biological Main Business Overview

13.5.5 Hualan Biological Latest Developments

13.6 Meheco Xinxing Pharma

13.6.1 Meheco Xinxing Pharma Company Information

13.6.2 Meheco Xinxing Pharma Human Prothrombin Complex Product Offered

13.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Meheco Xinxing Pharma Main Business Overview

13.6.5 Meheco Xinxing Pharma Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Human Prothrombin Complex Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Human Prothrombin Complex Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 500 IU/Vial

Table 4. Major Players of 600 IU/Vial

Table 5. Major Players of 1000 IU/Vial

Table 6. Major Players of Others

Table 7. Global Human Prothrombin Complex Sales by Type (2017-2022) & (K Units)

Table 8. Global Human Prothrombin Complex Sales Market Share by Type (2017-2022)

Table 9. Global Human Prothrombin Complex Revenue by Type (2017-2022) & ($ million)

Table 10. Global Human Prothrombin Complex Revenue Market Share by Type (2017-2022)

Table 11. Global Human Prothrombin Complex Sale Price by Type (2017-2022) & (M USD/Unit)

Table 12. Global Human Prothrombin Complex Sales by Application (2017-2022) & (K Units)

Table 13. Global Human Prothrombin Complex Sales Market Share by Application (2017-2022)

Table 14. Global Human Prothrombin Complex Revenue by Application (2017-2022)

Table 15. Global Human Prothrombin Complex Revenue Market Share by Application (2017-2022)

Table 16. Global Human Prothrombin Complex Sale Price by Application (2017-2022) & (M USD/Unit)

Table 17. Global Human Prothrombin Complex Sales by Company (2020-2022) & (K Units)

Table 18. Global Human Prothrombin Complex Sales Market Share by Company (2020-2022)

Table 19. Global Human Prothrombin Complex Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Human Prothrombin Complex Revenue Market Share by Company (2020-2022)

Table 21. Global Human Prothrombin Complex Sale Price by Company (2020-2022) & (M USD/Unit)

Table 22. Key Manufacturers Human Prothrombin Complex Producing Area Distribution and Sales Area

Table 23. Players Human Prothrombin Complex Products Offered

Table 24. Human Prothrombin Complex Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Human Prothrombin Complex Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Human Prothrombin Complex Sales Market Share Geographic Region (2017-2022)

Table 29. Global Human Prothrombin Complex Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Human Prothrombin Complex Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Human Prothrombin Complex Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Human Prothrombin Complex Sales Market Share by Country/Region (2017-2022)

Table 33. Global Human Prothrombin Complex Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Human Prothrombin Complex Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Human Prothrombin Complex Sales by Country (2017-2022) & (K Units)

Table 36. Americas Human Prothrombin Complex Sales Market Share by Country (2017-2022)

Table 37. Americas Human Prothrombin Complex Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Human Prothrombin Complex Revenue Market Share by Country (2017-2022)

Table 39. Americas Human Prothrombin Complex Sales by Type (2017-2022) & (K Units)

Table 40. Americas Human Prothrombin Complex Sales Market Share by Type (2017-2022)

Table 41. Americas Human Prothrombin Complex Sales by Application (2017-2022) & (K Units)

Table 42. Americas Human Prothrombin Complex Sales Market Share by Application (2017-2022)

Table 43. APAC Human Prothrombin Complex Sales by Region (2017-2022) & (K Units)

Table 44. APAC Human Prothrombin Complex Sales Market Share by Region (2017-2022)

Table 45. APAC Human Prothrombin Complex Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Human Prothrombin Complex Revenue Market Share by Region (2017-2022)

Table 47. APAC Human Prothrombin Complex Sales by Type (2017-2022) & (K Units)

Table 48. APAC Human Prothrombin Complex Sales Market Share by Type (2017-2022)

Table 49. APAC Human Prothrombin Complex Sales by Application (2017-2022) & (K Units)

Table 50. APAC Human Prothrombin Complex Sales Market Share by Application (2017-2022)

Table 51. Europe Human Prothrombin Complex Sales by Country (2017-2022) & (K Units)

Table 52. Europe Human Prothrombin Complex Sales Market Share by Country (2017-2022)

Table 53. Europe Human Prothrombin Complex Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Human Prothrombin Complex Revenue Market Share by Country (2017-2022)

Table 55. Europe Human Prothrombin Complex Sales by Type (2017-2022) & (K Units)

Table 56. Europe Human Prothrombin Complex Sales Market Share by Type (2017-2022)

Table 57. Europe Human Prothrombin Complex Sales by Application (2017-2022) & (K Units)

Table 58. Europe Human Prothrombin Complex Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Human Prothrombin Complex Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Human Prothrombin Complex Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Human Prothrombin Complex Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Human Prothrombin Complex Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Human Prothrombin Complex Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Human Prothrombin Complex Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Human Prothrombin Complex Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Human Prothrombin Complex Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Human Prothrombin Complex

Table 68. Key Market Challenges & Risks of Human Prothrombin Complex

Table 69. Key Industry Trends of Human Prothrombin Complex

Table 70. Human Prothrombin Complex Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Human Prothrombin Complex Distributors List

Table 73. Human Prothrombin Complex Customer List

Table 74. Global Human Prothrombin Complex Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Human Prothrombin Complex Sales Market Forecast by Region

Table 76. Global Human Prothrombin Complex Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Human Prothrombin Complex Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Human Prothrombin Complex Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Human Prothrombin Complex Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Human Prothrombin Complex Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Human Prothrombin Complex Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Human Prothrombin Complex Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Human Prothrombin Complex Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Human Prothrombin Complex Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Human Prothrombin Complex Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Human Prothrombin Complex Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Human Prothrombin Complex Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Human Prothrombin Complex Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Human Prothrombin Complex Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Human Prothrombin Complex Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Human Prothrombin Complex Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Human Prothrombin Complex Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Human Prothrombin Complex Revenue Market Share Forecast by Application (2023-2028)

Table 94. Takeda Basic Information, Human Prothrombin Complex Manufacturing Base, Sales Area and Its Competitors

Table 95. Takeda Human Prothrombin Complex Product Offered

Table 96. Takeda Human Prothrombin Complex Sales (K Units), Revenue ($ Million), Price (M USD/Unit) and Gross Margin (2020-2022)

Table 97. Takeda Main Business

Table 98. Takeda Latest Developments

Table 99. CSL Basic Information, Human Prothrombin Complex Manufacturing Base, Sales Area and Its Competitors

Table 100. CSL Human Prothrombin Complex Product Offered

Table 101. CSL Human Prothrombin Complex Sales (K Units), Revenue ($ Million), Price (M USD/Unit) and Gross Margin (2020-2022)

Table 102. CSL Main Business

Table 103. CSL Latest Developments

Table 104. Grifols Basic Information, Human Prothrombin Complex Manufacturing Base, Sales Area and Its Competitors

Table 105. Grifols Human Prothrombin Complex Product Offered

Table 106. Grifols Human Prothrombin Complex Sales (K Units), Revenue ($ Million), Price (M USD/Unit) and Gross Margin (2020-2022)

Table 107. Grifols Main Business

Table 108. Grifols Latest Developments

Table 109. Octapharma Basic Information, Human Prothrombin Complex Manufacturing Base, Sales Area and Its Competitors

Table 110. Octapharma Human Prothrombin Complex Product Offered

Table 111. Octapharma Human Prothrombin Complex Sales (K Units), Revenue ($ Million), Price (M USD/Unit) and Gross Margin (2020-2022)

Table 112. Octapharma Main Business

Table 113. Octapharma Latest Developments

Table 114. Hualan Biological Basic Information, Human Prothrombin Complex Manufacturing Base, Sales Area and Its Competitors

Table 115. Hualan Biological Human Prothrombin Complex Product Offered

Table 116. Hualan Biological Human Prothrombin Complex Sales (K Units), Revenue ($ Million), Price (M USD/Unit) and Gross Margin (2020-2022)

Table 117. Hualan Biological Main Business

Table 118. Hualan Biological Latest Developments

Table 119. Meheco Xinxing Pharma Basic Information, Human Prothrombin Complex Manufacturing Base, Sales Area and Its Competitors

Table 120. Meheco Xinxing Pharma Human Prothrombin Complex Product Offered

Table 121. Meheco Xinxing Pharma Human Prothrombin Complex Sales (K Units), Revenue ($ Million), Price (M USD/Unit) and Gross Margin (2020-2022)

Table 122. Meheco Xinxing Pharma Main Business

Table 123. Meheco Xinxing Pharma Latest Developments

List of Figures

Figure 1. Picture of Human Prothrombin Complex

Figure 2. Human Prothrombin Complex Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Human Prothrombin Complex Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Human Prothrombin Complex Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Human Prothrombin Complex Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 500 IU/Vial

Figure 10. Product Picture of 600 IU/Vial

Figure 11. Product Picture of 1000 IU/Vial

Figure 12. Product Picture of Others

Figure 13. Global Human Prothrombin Complex Sales Market Share by Type in 2021

Figure 14. Global Human Prothrombin Complex Revenue Market Share by Type (2017-2022)

Figure 15. Human Prothrombin Complex Consumed in Hemophilia B

Figure 16. Global Human Prothrombin Complex Market: Hemophilia B (2017-2022) & (K Units)

Figure 17. Human Prothrombin Complex Consumed in Vitamin K Deficiency

Figure 18. Global Human Prothrombin Complex Market: Vitamin K Deficiency (2017-2022) & (K Units)

Figure 19. Human Prothrombin Complex Consumed in Others

Figure 20. Global Human Prothrombin Complex Market: Others (2017-2022) & (K Units)

Figure 21. Global Human Prothrombin Complex Sales Market Share by Application (2017-2022)

Figure 22. Global Human Prothrombin Complex Revenue Market Share by Application in 2021

Figure 23. Human Prothrombin Complex Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Human Prothrombin Complex Revenue Market Share by Company in 2021

Figure 25. Global Human Prothrombin Complex Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Human Prothrombin Complex Revenue Market Share by Geographic Region in 2021

Figure 27. Global Human Prothrombin Complex Sales Market Share by Region (2017-2022)

Figure 28. Global Human Prothrombin Complex Revenue Market Share by Country/Region in 2021

Figure 29. Americas Human Prothrombin Complex Sales 2017-2022 (K Units)

Figure 30. Americas Human Prothrombin Complex Revenue 2017-2022 ($ Millions)

Figure 31. APAC Human Prothrombin Complex Sales 2017-2022 (K Units)

Figure 32. APAC Human Prothrombin Complex Revenue 2017-2022 ($ Millions)

Figure 33. Europe Human Prothrombin Complex Sales 2017-2022 (K Units)

Figure 34. Europe Human Prothrombin Complex Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Human Prothrombin Complex Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Human Prothrombin Complex Revenue 2017-2022 ($ Millions)

Figure 37. Americas Human Prothrombin Complex Sales Market Share by Country in 2021

Figure 38. Americas Human Prothrombin Complex Revenue Market Share by Country in 2021

Figure 39. United States Human Prothrombin Complex Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Human Prothrombin Complex Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Human Prothrombin Complex Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Human Prothrombin Complex Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Human Prothrombin Complex Sales Market Share by Region in 2021

Figure 44. APAC Human Prothrombin Complex Revenue Market Share by Regions in 2021

Figure 45. China Human Prothrombin Complex Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Human Prothrombin Complex Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Human Prothrombin Complex Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Human Prothrombin Complex Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Human Prothrombin Complex Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Human Prothrombin Complex Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Human Prothrombin Complex Sales Market Share by Country in 2021

Figure 52. Europe Human Prothrombin Complex Revenue Market Share by Country in 2021

Figure 53. Germany Human Prothrombin Complex Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Human Prothrombin Complex Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Human Prothrombin Complex Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Human Prothrombin Complex Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Human Prothrombin Complex Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Human Prothrombin Complex Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Human Prothrombin Complex Revenue Market Share by Country in 2021

Figure 60. Egypt Human Prothrombin Complex Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Human Prothrombin Complex Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Human Prothrombin Complex Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Human Prothrombin Complex Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Human Prothrombin Complex Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Human Prothrombin Complex in 2021

Figure 66. Manufacturing Process Analysis of Human Prothrombin Complex

Figure 67. Industry Chain Structure of Human Prothrombin Complex

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390